Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease

Recruiting now

Conditions studied: Rheumatoid Arthritis, Interstitial Lung Disease

In brief

A study to identify patients with Rheumatoid Arthritis - Associated Interstitial Lung Disease (RA-ILD) that are at the highest risk for progression. The goal of the investigators is to recruit a group of patients with RA-ILD and collect information to help us understand more about disease progression. The investigators will do this using a combination of clinical, radiologic, and biologic features.

Key facts

Study ID

NCT06397677

Run by

University of Colorado, Denver

People needed

450

Starts

2024-01-22

Expected to finish

2034-01-01

Last updated by the study team

2024-05-03

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Multidisciplinary diagnosis of RA-ILD based on the 2010 American College of Rheumatology criteria
• 18 years of age or older

You may not qualify if…

• Prior medication treatment specifically for RA-ILD
• Inability to give informed consent
• Pregnant women

Where it is running

• University of California San Francisco — San Francisco, California, United States (enrolling)
• University of Colorado Denver — Aurora, Colorado, United States (enrolling)
• University of Kansas — Kansas City, Kansas, United States (enrolling)
• University of Michigan — Ann Arbor, Michigan, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.